Introduction Menopause is often viewed simply as the end of a woman’s reproductive years, but modern medicine now understands it as a profound systemic and neurological transition. As the body’s natural hormone production changes, women may experience a wide range of physical, metabolic, and cognitive changes. Understanding these changes—and the cutting-edge therapies available to address them—is key to maintaining vitality, brain health, and a high quality of life during this new chapter.

AVERAGE AGE OF MENOPAUSE IN MEXICO  

 When preparing for hormonal transitions, it’s helpful to look at regional data. The average age of menopause for women in Mexico is approximately 48 to 49 years , which is slightly earlier than the global average of 51 years. Factors such as genetics, lifestyle, diet, and socioeconomic background can influence the exact timing of this transition. Recognizing this timeline allows women to proactively seek hormone panels and lifestyle interventions during perimenopause (the transition years leading up to menopause) rather than waiting for symptoms to become severe.

 HORMONAL CHANGES DURING MENOPAUSE    

 The menopausal transition is characterized by a massive fluctuation and eventual drop in key hormones. This is exactly what happens in the body:

• Estrogen Decline: Estrogen is a master regulator in the female body. Its decline is responsible for classic menopausal symptoms, including hot flashes, night sweats, and vaginal dryness. In addition, estrogen loss affects skin elasticity, bone density, and cardiovascular health.
• Decreased Progesterone: Progesterone is the body’s natural «calming» hormone and is usually the first to decline during perimenopause. This decrease often leads to increased anxiety, mood swings, and severe sleep disturbances.
• Metabolic Changes: Hormonal changes directly affect body composition. As estrogen and progesterone levels decline, women often experience increased insulin resistance, making it easier to gain weight—particularly visceral fat around the abdomen—and harder to maintain lean muscle mass.
• Brain Changes: We now know that menopause is largely a neurological transition . Estrogen plays a vital role in the brain’s energy metabolism. When estrogen levels decline, the brain’s ability to use glucose efficiently is impaired, which can lead to mental confusion, memory problems, and an increased risk of neurological decline.

  HORMONE THERAPY OPTIONS FOR MENOPAUSE  

 Hormone Replacement Therapy (HRT) has evolved significantly, offering targeted relief and long-term protective benefits.

• Estrogen Therapy (Connecting with Kisspeptin and Oxytocin): Replacing estrogen helps eliminate hot flashes and protects bone and heart health. Interestingly, estrogen is deeply connected to a neuropeptide called kisspeptin . When estrogen levels drop, kisspeptin neurons in the brain become overactive, directly triggering the debilitating hot flashes and sweats of menopause. Estrogen therapy calms these neurons. In addition, healthy estrogen levels support the production and sensitivity of oxytocin receptors (the «love» and «bonding» hormone), helping to stabilize mood, reduce stress, and promote a sense of well-being.
• Progesterone: For women who still have their uterus, taking bioidentical progesterone along with estrogen is medically necessary to protect the uterine lining. Even without a uterus, many women benefit from progesterone because of its ability to promote deep, restorative sleep and reduce anxiety.
• Testosterone for Women: Testosterone isn’t just a male hormone; it’s the most abundant active steroid hormone in the female body. As testosterone levels decline with age, women experience a loss of energy, motivation, and sex drive. Low-dose testosterone therapy for women offers a transformative approach to restoring libido, maintaining muscle mass, and improving overall drive and mental clarity.

PEPTIDES AND HORMONAL OPTIMIZATION 

 In addition to traditional HRT, modern longevity medicine uses peptide therapies to optimize healthy lifespan and combat the physical signs of aging during menopause:

• CJC-1295 and Ipamorelin: These are growth hormone-releasing peptides (GHRPs) and growth hormone-releasing hormones (GHRH). During menopause, natural growth hormone levels plummet, leading to poor recovery and muscle loss. This peptide combination gently stimulates the pituitary gland to naturally produce more growth hormone, aiding in deep sleep, cell repair, and the preservation of lean muscle.
• Tesamorelin: Known for its potent metabolic effects, tesamorelin is highly effective at targeting and reducing visceral adipose tissue (the dangerous abdominal fat that easily accumulates during menopause due to metabolic changes).
• PT-141 (Bremelanotide): While testosterone helps with sex drive , PT-141 is an FDA-approved peptide specifically designed to treat Hypoactive Sexual Desire Disorder (HSDD) in pre- and postmenopausal women. It works directly on the central nervous system to boost sexual arousal and restore healthy sexual function.

Expert Highlight: Dr. Lisa Mosconi on the Brain in Menopause To truly understand the impact of menopause, we must look at how it affects the brain. Dr. Lisa Mosconi is a world-renowned neuroscientist, Director of the Women’s Brain Initiative, and Associate Director of the Alzheimer’s Prevention Clinic at Weill Cornell Medicine.

Her pioneering research focuses on how the female brain is uniquely wired for estrogen. In her insightful appearance on the Diary of a CEO (DOAC) podcast , she explains that menopause is not just an ovarian event, but a neurological one. Her brain imaging research reveals that as estrogen declines, the brain actually experiences a temporary «energy crash,» which explains the profound mental fog and mood swings women experience. Crucially, her work highlights how optimizing hormonal health and lifestyle during the menopausal transition is vital for preventing Alzheimer’s disease, which disproportionately affects women.

• Listen to the podcast: https://www.youtube.com/watch?v=ej-ie5unHlU
• Read the research: https://pmc.ncbi.nlm.nih.gov/articles/PMC8190071/